Clinical application of the PKG® system
The PKG® provides objective, ambulatory, continuous assessment of motor complications associated with movement disorders including:
- Assessment of bradykinesia, dyskinesia and tremor
- Ability to correlate symptom fluctuations and their severity with respect to levodopa dosage
- Self-reported levodopa compliance
- A record of daytime sleepiness and immobility
- Assessment of the risk of Impulse Control Disorders
News & Events
April 2022 – Parkinson’s Patients Benefit From Revolutionary Watch on the NHS to Manage Care at Home
Patients with Parkinson’s disease are being given life-changing smart watches...
Sept 2021 – Watch the latest video – Thomas & Karen discuss the benefits of using the PKG for clinical trials
Sept 2021 – Listen to Project Medtech: Episode 58 with Karen Krygier, Utilizing RPM Codes & Remote Patient Monitoring in Clinical Trials
Project Medtech: Episode 58 with Karen Krygier, Utilizing RPM Codes &...
Aug 2021 – Press release – Global Kinetics Enters Remote Monitoring Business and Appoints New U.S. Commercial Leadership
August 19, 2021 – Global Kinetics Pty Ltd (GK) announced...
Dec 2021 – Thomas Ulmer appointed as Chief Financial Officer
Thomas Ulmer as Chief Financial Officer (CFO), effective April 2021....
GK is committed to supporting customers through the COVID-19 pandemic
As members of the global healthcare community, it is our...
Nov 2019 – PKG Wristwatch Device May Improve Clinical Decision-Making in Parkinson’s, Study Shows
A wrist-worn medical device — called the Personal KinetiGraph or PKG —...